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A factor which markedly activates Caz+-dependent thiol protease (calpain) is associated with Triton X-lOO- 
insoluble materials, presumably structural elements uch as cytoskeletons, of bovine brain microsomal frac- 
tion. This factor is extracted with 0.6 M KCl, and purified partially by sucrose density gradient centrifuga- 
tion and hydroxyapatite column chromatography. The factor appears to be a heat-stable protein with an 
approximate M, of 15 000. With casein as substrate this factor activates both calpain I and calpain II several- 
fold up to more than lo- fold without alteration of their affinity to Ca 2+. Calmodulin is unable to substitute 
for this factor. A similar factor is associated with human platelet insoluble materials. 
Calpain Calpain activator Protease 
1. INTRODUCTION 
Ca’+-dependent hiol protease (calpain) has 
been described by Guroff [l] and Meyer et al. [2], 
and subsequently found in various mammalian 
and avian tissues (reviews, see [3-51). This family 
of proteases appears to catalyze limited proteolysis 
of a limited number of proteins, such as those 
related to contractile and cytoskeletal machineries 
[6-131. Since a class of calpains sensitive to the 
micromolar range of Ca2+ (calpain I) are known to 
occur in most tissues [5,14-l 81 including bovine 
brain cytosol [ 131, attempts have been made to 
clarify their role in many Ca2+-mediated 
physiological processes. Although an inhibitor 
protein (calpastatin) specific to calpain has been 
characterized from mammalian tissues [5,19], little 
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is known about the activator of this family of en- 
zymes. DeMartino and Blumenthal [20] have 
described a heat-stable protein partially purified 
from bovine brain cytosol, which activates 
markedly both calpain I and calpain II that are ac- 
tive in the micromolar and millimolar ranges of 
Ca’+, respectively. The present communication 
will briefly describe a similar activator which is 
associated primarily with Triton X-lOO-insoluble 
materials, presumably structural elements from 
bovine brain microsomal fraction. 
2. MATERIALS AND METHODS 
2.1. Materials 
Crude microsomal fraction (216 mg protein) 
was prepared from freshly obtained bovine brain 
cortex (40 g wet wt), and treated with 2% Triton 
X-100 to remove any soluble materials by the pro- 
cedure described in [21]. The Triton X-lOO-in- 
soluble materials, consisting of presumably cyto- 
skeletal proteins [21], were washed twice with an 
excess volume of 10 mM sodium phosphate, at pH 
7.4, containing 126 mM NaCl, 5 mM KC1 and 
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0.3 mM EDTA. The residue (57 mg protein), 
referred to as the Triton-insoluble fraction, was 
employed as starting material. Calpain I and cal- 
pain II were purified from rat brain cytosol as 
described in [ 181 and [22], respectively. Bovine 
brain calmodulin was a gift from Dr S. Kakiuchi 
and Dr K. Sobue, Osaka University. Human 
platelets were obtained from healthy volunteers. 
2.2. Assays of calpain and activator 
Calpain was assayed by measuring the forma- 
tion of acid-soluble radioactive materials with 12’1- 
casein as substrate as described in [ 181. Detailed 
conditions are given in the legend to fig. 1. Calpain 
I and calpain II were assayed at 5 x 10m4 and 2 x 
lob3 M CaClz, respectively, unless otherwise 
noted. One unit of the enzyme was defined as that 
amount of enzyme which catalyzed the conversion 
of 1 ng casein to an acid-soluble form per min. 
One unit of activator was defined as that amount 




calpain. The efficiencies of the factor in activating 
calpain I and calpain II were nearly identical. 
2.3. Chemicals and determinations 
cu-Chymotrypsin was a product of Worthington, 
and other chemicals were obtained from commer- 
cial sources. The radioactivity of 125I samples were 
determined using a Aloka Auto-Well Gamma 
System, model ARC-251. The molecular mass of 
protein was roughly estimated by sucrose density 
gradient analysis and gel filtration procedure as 
described in [23]. Protein was determined ac- 
cording to Lowry et al. [24] with bovine serum 
albumin as a standard. 
3. RESULTS 
3.1. Partidi purification 
Triton-insoluble fraction (57 mg protein) 
prepared from bovine brain microsomal fraction 
was homogenized with 10 ml of 10 mM Pipes 
I I I 
-0.6 
Fraction Number 
Fig. 1. Calpain activator from bovine brain microsomal-insoluble fraction. (A) Sucrose density gradient centrifugation 
analysis. (B) Hydroxyapatite column chromatography. Detailed conditions are described in the text. A 40 ,ul aliquot of 
each fraction was assayed for the activator with calpain II as test enzyme. The reaction mixture (0.1 ml) contained 
1 /rmol Tris-HCl (pH 7.5), 0.5 pmol 2-mercaptoethanol, 10 pg ‘2SI-casein (4 x 104 cpm/pg), 0.2 pmol CaCl2 and 
approx. 1 unit (22 ,ug) calpain II. The reaction was started by the addition of CaC12, and allowed to proceed for 30 min 
at 20°C. The reaction was linear with time. The parallel incubation was made with 25 nmol EGTA instead of CaC12. 
The reaction was stopped and the acid-soluble radioactivity was determined as described in [ 181. (o---o) Protease 
activity, (- - -) potassium phosphate. 
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(piperazine-N,N’-bis(2-ethanesulfonic acid)) at 
pH 6.8, containing 0.6 M KC1 and 2 mM NaN3 
(buffer A), using a Teflon-glass homogenizer and 
the homogenate was centrifuged for 3 h at 
105000 x g. The precipitate was re-extracted with 
5 ml buffer A, and the supernatants were com- 
bined. The KC1 extract (16 mg protein) was con- 
centrated to 2 ml by an Amicon ultrafiltration cell 
equipped with a YM-2 filter membrane. An aliquot 
of 0.2 ml was then layered on a 4.8 ml linear 
sucrose concentration gradient (5-20%) in buffer 
A. After centrifugation for 20 h at 45000 rpm in 
an SW-50.1 rotor of a Beckman model LS-50 
ultracentrifuge, fractions of 0.20 ml were col- 
lected. The activator appeared as a peak in fraction 
20 (fig.lA). Fractions 19-21 were pooled (0.26 mg 
protein) and directly applied to a hydroxyapatite 
column (4 x 1.5 cm) equilibrated with buffer A. 
After the column was washed with 20 ml buffer A, 
the factor was eluted with a concentration gradient 
(O-O.5 M) of potassium phosphate (pH 6.8) in 
14 ml buffer A. Fractions of 0.7 ml were collected. 
The activator was eluted in fraction 5 (fig.lB). 
Fractions 4-6 were pooled (0.16 mg protein) and 
concentrated to 1 ml. By this procedure the ac- 
tivator was purified about 30-fold with an approx- 
imate recovery of 10% (table 1). This factor will be 
referred to tentatively as calpain activator. 
3.2. Properties 
Calpain activator purified partially as described 
above stimulated greatly the hydrolysis of casein 
catalyzed by calpain I as well as by calpain II. This 
activation of proteolysis was directly proportional 
Table 1 
Partial purification of calpain activatora 
Fraction Total Total Specific Yield 
protein activity activity (Ore) 
(mg) (units) (units/ 
mg 
protein) 
Triton insoluble 57 2800 49 100 
KC1 extract 16 1400 88 55 
Sucrose density 
gradient 0.26 340 1307 12 
Hydroxyapatite 0.16 250 1563 9 
a Starting from 40 g fresh bovine brain cortex 
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to the quantity of the activator added. The ac- 
tivator per se showed no enzymatic activity. The 
result given in fig.2 was obtained for calpain II, 
and the activator was equally effective for calpain 
I. The factor was very stable to heat, and not inac- 
tivated by being maintained for 10 min at 95°C. It 
was nevertheless inactivated completely by treat- 
ment with digestive proteases such as cy- 
chymotrypsin. It behaved as a single component 
with an approximate M, of 15 000. A homogeneous 
preparation of bovine brain calmodulin could not 
substitute for this activator, and calmodulin in- 
hibitors such as chlorpromazine showed no effect 
over a wide range of concentrations. Neither the 
enzyme preparations nor the activator contained a 
known inhibitor, calpastatin, and the observed ef- 
fect of the activator did not appear to be due to its 
competition with some inhibitory proteins. Fig.3 
shows the activation of calpain I and calpain II by 




I I I T 
Q-c 
I^  I I 01 
0 2 4 6 8 
Activator o.@assaY tube) 
Fig.2. Effect of calpain activator on casein hydrolysis by 
calpain. Various amounts of purified activator were 
added under the conditions specified in fig. 1. Calpain II 
(2 units, 45 pg) was used. (M) Calpain II plus 
activator, (m) activator alone. 
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the app~ent _& value for this divalent cation was 
not significantly modified. 
The stimulatory effect of calpain activator 
seemed to be specific for calpain I and calpain II, 
and was not observed for proteolytic reactions 
catalyzed by other proteases uch as trypsin. The 
stimulation was not due to some intrinsic protease 
activity, like exopeptidase activity, of the factor, 
since casein hydrolysis was not enhanced when it 
was added after the reaction by calpain had ended. 
The apparent Km value for casein was not affected 
by this factor. 
Calpain activator appeared to be associated 
primarily with Triton X-lOO-insoluble materials, 
and seemingly very poor, if present, in the cytosol 
and Triton X-lOO-extractable fraction. This ap- 
parent lack of the activator in soluble fractions was 
not simply due to masking it by another heat-stable 
protein, calpastatin, which normally showed an 
approximate M, of 28Ow in most tissues [5]. An 
activator of calpain similar to the brain activator 
was also associated with the Triton X-lOO-in- 
soluble materials obtained from human platelets. 
a 
0.5 1.0 2.0 
Ml2 Added (a% 
Fig.3. Activation of calpain I and calpain II by calpain 
activator in the presence of various concentrations of 
CaC12. The experimental conditions were similar to 
those given in fig.1, except that various concentrations 
of CaC12 were added. (A) With calpain I (2 units, 10 pg). 
(B) With calpain II (2 units, 45&g). Where indicated 
EGTA was added at a final concentration of 0.5 mM. 
(w) Calpain plus calpain activator, (O---O) calpain 
alone. 
4. DISCUSSION 
Attention has been increasingly paid to 
Ca2+-dependent thiol proteases, calpains, that are 
present widely in most tissues, in the hope that this 
family of enzymes may have some functions in the 
control of various Ca2+-mediated cellular pro- 
cesses, particularly in stimulus-response coupling 
[5]. Calpains from many tissues are located prin- 
cipally in the cytosol, and show a molecular mass 
of approx. 110 kDa, usually composed of 72-82 
and 25-30 kDa subunits 151. The smaller subunit 
obtained from bovine brain shows an approximate 
Mr of 17000 and is required for maximum activity 
of the larger subunit [13,25]. An activator of cal- 
pain partially purified by DeMartino and Blumen- 
thal 1201 from bovine brain cytosol is apparently 
similar to the activator described in this paper, but 
its amount in the cytosol is extremely small 
(20-30,ug/40 g brain) [20]. It is possible that this 
cytosol activator is identical with that described 
here, and is associated primarily with some struc- 
tural elements. 
Although the biological role of this family of en- 
zymes remains unknown, it is worth noting that 
the enzymes cleave preferentially contractile and 
cytoskeletal proteins such as neurotubules, 
neurofilaments and desmin [6-131. It is attractive 
to imagine that the activator associated with such 
structural elements may have a function in 
stimulating their limited proteolysis by calpain, 
and plays a role in the processes of stimulus- 
response coupling such as release reactions and 
exocytosis. 
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